natriumkromat (cr-51) ge healthcare 37 mbq/ml stamlösning till radioaktiva läkemedel
ge healthcare limited - natriumkromat(cr-51) - stamlösning till radioaktiva läkemedel - 37 mbq/ml - natriumkromat(cr-51) 37 mbq aktiv substans - natriumkromat(cr-51)
tallium (tl-201) klorid curiumpharma 37 mbq/ml injektionsvätska, lösning
curium netherlands b.v. - tallium(tl-201)klorid - injektionsvätska, lösning - 37 mbq/ml - tallium(tl-201)klorid 37 mbq aktiv substans - tallium(tl-201)klorid
cardiogen-82 3,3-5,6 gbq radionuklidgenerator
bracco imaging spa - rubidium(rb-82)klorid; strontium(sr-82)klorid - radionuklidgenerator - 3,3-5,6 gbq - strontium(sr-82)klorid 3,3 - 5,6 gbq aktiv substans; rubidium(rb-82)klorid 3,3 - 5,6 gbq aktiv substans
tallium(t1-201)klorid ge healthcare 37 mbq/ml injektionsvätska, lösning
ge healthcare limited - tallium(tl-201)klorid - injektionsvätska, lösning - 37 mbq/ml - tallium(tl-201)klorid 37 mbq aktiv substans; bensylalkohol hjälpämne - tallium(tl-201)klorid
tallium (tl-201)klorid map 37 mbq/ml injektionsvätska, lösning
map medical technologies oy - tallium(tl-201)klorid - injektionsvätska, lösning - 37 mbq/ml - tallium(tl-201)klorid 37 mbq aktiv substans - tallium(tl-201)klorid
tallium (tl-201) klorid cis 37 mbq/ml injektionsvätska, lösning
cis bio international - tallium(tl-201)klorid - injektionsvätska, lösning - 37 mbq/ml - tallium(tl-201)klorid 37 mbq aktiv substans - tallium(tl-201)klorid
ruby-fill 3,7 gbq radionuklidgenerator
jubilant pharmaceuticals nv - rubidium(rb-82)klorid; strontium(sr-82)klorid - radionuklidgenerator - 3,7 gbq - strontium(sr-82)klorid 3,7 gbq aktiv substans; rubidium(rb-82)klorid 3,7 gbq aktiv substans
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiska medel - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
vyvgart
argenx - efgartigimod alfa - myasthenia gravis - immunsuppressiva - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.
xylocain 100 mg/ml kutan spray, lösning
aspen pharma trading limited - lidokain - kutan spray, lösning - 100 mg/ml - etanol, vattenfri hjälpämne; lidokain 100 mg aktiv substans - lidokain